Vivek Subbiah: Incredibly excited to team up and be featured in the national news on World Cancer Research Day

Vivek Subbiah shared a post on X:

“Today is World Cancer Research Day! We are incredibly excited to team up and be featured in the national news at NewsNation!  It is an honor to share our message and discuss the groundbreaking advances in cancer research that are leading to unprecedented progress.  Special thanks to News Nation for featuring Dr. Erika Hamilton MD world-renowned breast medical oncologist, and me in spreading this message of hope.

Together, we are all making strides toward a future where cancer is no longer a formidable foe Sarah Cannon Docs, SCRI Oncology Partners, The US Oncology Network.

Tune in to the link from live news segment to learn more about the latest developments and how they are changing lives.”

Source: Vivek Subbiah/X

Vivek Subbiah is the Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA). He is the former Executive Director of Oncology Research and former Associate Professor in the Department of Investigational Cancer Therapeutics at the MD Anderson Cancer He focuses on translational cancer research and the design and implementation of early-phase biomarker-driven clinical trials. His work specifically targets antibody-drug conjugates, radiopharmaceuticals, immunoconjugates, and basket trials.